• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy & Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Press Releases
    • Media Requests
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

Tocilizumab (Actemra®)

March 2, 2018

Selected References:

  • Actemra Prescribing Information. Available online at https://www.gene.com/download/pdf/actemra_prescribing.pdf [Accessed Jan 2020].
  • Förger F & Villiger PM. 2016. Treatment of rheumatoid arthritis during pregnancy: present and future, Expert Rev of Clin Immun; 12(9):937-944.
  • Götestam Skorpen C, et al. 2016. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Annals of the Rheum Dis; 75:795-810.
  • Hoeltzenbein M, et al. 2016. Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data. Sem Arthr Rheum; 466(2):238–45.
  • Hyrich KL and Verstappen SM. 2014. Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford); 53(8):1377-85.
  • Levy RA, et. al. 2016. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmun Rev 15(10):955-63.
  • Kaneko K, et. al. 2016. Tocilizumab and pregnancy: Four cases of pregnancy in young women with rheumatoid arthritis refractory to anti-TNF biologics with exposure to tocilizumab. Mod Rheumtol ; 26(5):672-675.
  • Nakajima K, et. al. 2016. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. Mod Rheumtol; 26(5):667-671.
  • Ostensen M and Förger F. 2011. Treatment with biologics of pregnant patients with rheumatic diseases. Curr Opin Rheumatol; 23(3):293-8.
  • Pham T, et al. 2010.Tocilizumab: therapy and safety management. Joint Bone Spine; 77 Suppl 1:S3-100.
  • Rubbert-Roth A, et al. 2010. First experiences with pregnancies in RA patients receiving tocilizumab therapy. [abstract]. Arthritis Rheum; 62 Suppl 10:384.
  • Saito J, et. al. 2018. Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: A case study. Rheumatology (Oxford). 57:1499-501.
  • Saito J et. al. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology (Oxford). 58(8):1505-1507.
  • Weber-Schoendorfer C and Schaefer C. 2016. Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center. Reprod Toxicology. 60:29–32.

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whopping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
615.349.3082
contactus@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2021 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^